Literature DB >> 15836454

The ileocolonic sphincter.

C-H Malbert1.   

Abstract

The human ileocolonic sphincter (ICS) develops a sustained tone mainly due to propagated and not propagated phasic motor activity. The ileocaecocolonic segment is also able to behave, yet uncommonly, as a synchronized segment involving propagated contractions originating from the ileum and migrating to the proximal colon. The ICS motor activity alone has a limited role towards forward flow. On the contrary, the functional entity corresponding to the distal ileum and the ICS provides a clearance mechanism for reflux of colonic contents into the small intestine. The presence of short chain fatty acids (SCFA) in the distal ileum, sensed either by endocrine cells or chemo-sensitive vagal afferents, is an important actor in triggering this clearance mechanism. The ICS tone is in part myogenic but a neuronal nitrergic component is also involved. Reflex excitatory and inhibitory responses of the ICS originating from ileal or colonic distension involve primarily spinal nitrergic and adrenergic pathways.

Entities:  

Mesh:

Year:  2005        PMID: 15836454     DOI: 10.1111/j.1365-2982.2005.00657.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  21 in total

Review 1.  A review of mixing and propulsion of chyme in the small intestine: fresh insights from new methods.

Authors:  R G Lentle; C de Loubens
Journal:  J Comp Physiol B       Date:  2015-02-04       Impact factor: 2.200

2.  Transverse colon perforation due to carcinoma rectum: an unusual presentation against Laplace's law.

Authors:  Manash Ranjan Sahoo; Anil Kumar; Sunil Jaiswal; Basavaraja C
Journal:  BMJ Case Rep       Date:  2013-08-16

3.  Functional outcome, quality of life, and efficacy of probiotics in postoperative patients with colorectal cancer.

Authors:  Seiji Ohigashi; Yoshinori Hoshino; Sachiko Ohde; Hisashi Onodera
Journal:  Surg Today       Date:  2011-08-26       Impact factor: 2.549

4.  Protective effects of terminal ileostomy against bacterial translocation in a rat model of intestinal ischemia/reperfusion injury.

Authors:  Zhi-Liang Lin; Wen-Kui Yu; Shan-Jun Tan; Kai-Peng Duan; Yi Dong; Xiao-Wu Bai; Lin Xu; Ning Li
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

5.  Ileocaecal valve: how important is it?

Authors:  S Folaranmi; G Rakoczy; J Bruce; G Humphrey; J Bowen; A Morabito; P Kapur; J Morecroft; R Craigie; T Cserni
Journal:  Pediatr Surg Int       Date:  2011-06       Impact factor: 1.827

6.  Enteroenteroanastomosis near adjacent ileocecal valve in infants.

Authors:  Wei-Wei Jiang; Xiao-Qun Xu; Qi-Ming Geng; Jie Zhang; Huan Chen; Xiao-Feng Lv; Chang-Gui Lu; Wei-Bing Tang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

7.  Effects of aging on the architecture of the ileocecal junction in rats.

Authors:  Maria Cícera de Brito; Renato Paulo Chopard; Diego Pulzatto Cury; Ii Sei Watanabe; Cristina Eusébio Mendes; Patricia Castelucci
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-08-06

Review 8.  Principles and clinical implications of the brain-gut-enteric microbiota axis.

Authors:  Sang H Rhee; Charalabos Pothoulakis; Emeran A Mayer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

Review 9.  Diabetic gastrointestinal motility disorders and the role of enteric nervous system: current status and future directions.

Authors:  S S Yarandi; S Srinivasan
Journal:  Neurogastroenterol Motil       Date:  2014-03-24       Impact factor: 3.598

10.  Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease.

Authors:  Andrew M Smith; Farooq Z Rahman; Bu'Hussain Hayee; Simon J Graham; Daniel J B Marks; Gavin W Sewell; Christine D Palmer; Jonathan Wilde; Brian M J Foxwell; Israel S Gloger; Trevor Sweeting; Mark Marsh; Ann P Walker; Stuart L Bloom; Anthony W Segal
Journal:  J Exp Med       Date:  2009-08-03       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.